Latest Market News

Tambourah Metals is seeking up to $2.203 million through a non-renounceable one-for-four entitlement offer to fund exploration across its Western Australian portfolio. The offer is not underwritten, and the prospectus warns that further equity may be needed to support the company beyond the short term.

SKS Technologies has denied knowledge of undisclosed information after ASX queried a sharp share price reversal and significant trading volume. The company said its projects, work in hand and data centre opportunity pipeline remained unchanged.

49 Metals says every hole in its maiden Gold Mountain campaign intersected gold or silver, including a high-grade 27.4-metre interval and a 170.7-metre broad intercept. A second drilling campaign is now testing whether the Adit Zone has the continuity and scale needed to support a maiden mineral resource estimate in 2027.

Paladin Energy kept its FY2027 production and cost targets unchanged despite a softer first quarter at Langer Heinrich, where planned maintenance and lower recovery reduced output. Higher realised uranium prices and progress at the Patterson Lake South project provided the more constructive elements of the update.

Bubs Australia delivered 9.2% revenue growth and a sharp underlying EBITDA improvement in FY26, but statutory losses, weaker margins and negative operating cash flow expose the cost of its expansion. Permanent US FDA authorisation removes a major regulatory hurdle, while the annual report still flags material uncertainty around ongoing funding and cash generation.

IAG has offered a package of competition remedies to support approval of its proposed 20-year insurance alliance with RAC of Western Australia, including the transfer of NRMA policy renewal rights and a $20 million community investment. The insurer says the transaction still carries $1.2 billion in additional annual gross written premium and approximately $100 million in annual pre-tax synergies once integration is complete.

Elixinol Wellness lifted Q3 gross profit 27% and delivered a fourth consecutive quarter of positive underlying operating cash flow, despite statutory operating cash flow remaining negative and cash below A$1 million. The proposed all-scrip Vitable acquisition could add scale, but shareholder approval and a thin liquidity buffer remain important next tests.

Clever Culture Systems has appointed PSC Biotech as its sole sales agent for APAS Independence across pharmaceutical manufacturing markets in the US, Canada and Singapore. The agreement expands CCS’s reach beyond its direct focus on major global drugmakers, but any material revenue uplift is not expected before FY28.

Azzuro Resources will raise A$3.06 million from Kerry Resources Logistics at a premium to market, giving the Mongolian explorer funding for resource definition and technical studies. The deal would make Kerry a 19.9% shareholder, although completion is still expected on 19 October.

Talga has moved Talnode-C from qualification into commercial shipments, completed key engineering work for its staged Vittangi project and secured major Swedish permits. But the battery materials developer remains loss-making, cash-burning and reliant on further funding to continue development.

Promisia Healthcare has maintained group care occupancy at 96%, above its 95% target, while completing the Chatswood acquisition and preparing to potentially accelerate full ownership of Golden View Village. FY27 underlying EBITDAF guidance of at least $8.0 million remains unchanged for the existing portfolio, with updated guidance due in November.

Zenith Minerals has reaffirmed its support for Forrestania Resources’ takeover, arguing that the completed Edna May acquisition and A$310 million capital raising outweigh a sharply lower implied offer value. The recommendation comes with a clear split: long-term shareholders may favour the combination, while shorter-term holders may reasonably reject it.